BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17806133)

  • 1. Fitting observed and theoretical choices - women's choices about prenatal diagnosis of Down syndrome.
    Seror V
    Health Econ; 2008 May; 17(5):557-77. PubMed ID: 17806133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff?
    Grobman WA; Dooley SL; Welshman EE; Pergament E; Calhoun EA
    Prenat Diagn; 2002 Dec; 22(13):1195-200. PubMed ID: 12478632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women.
    Caughey AB; Washington AE; Kuppermann M
    Am J Obstet Gynecol; 2008 Mar; 198(3):333.e1-8. PubMed ID: 18177830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage.
    Chan YM; Leung TN; Leung TY; Fung TY; Chan LW; Lau TK
    Prenat Diagn; 2006 Sep; 26(9):819-24. PubMed ID: 16832829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome.
    Reid B; Sinclair M; Barr O; Dobbs F; Crealey G
    Soc Sci Med; 2009 Dec; 69(11):1561-73. PubMed ID: 19783085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
    Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
    Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic differences in determinants of participation and non-participation in prenatal screening for Down syndrome: a theoretical framework.
    Fransen MP; Essink-Bot ML; Oenema A; Mackenbach JP; Steegers EA; Wildschut HI
    Prenat Diagn; 2007 Oct; 27(10):938-50. PubMed ID: 17597492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of decision analysis to evaluate patients' choices of diagnostic prenatal test.
    Verp MS; Heckerling PS
    Am J Med Genet; 1995 Sep; 58(4):337-44. PubMed ID: 8533842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The choice of detecting Down syndrome: does money matter?
    Garrouste C; Le J; Maurin E
    Health Econ; 2011 Sep; 20(9):1073-89. PubMed ID: 21671303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive validity of prospect theory versus expected utility in health utility measurement.
    Abellan-Perpiñan JM; Bleichrodt H; Pinto-Prades JL
    J Health Econ; 2009 Dec; 28(6):1039-47. PubMed ID: 19833400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening.
    Seror V; Ville Y
    Prenat Diagn; 2009 Feb; 29(2):120-8. PubMed ID: 19123253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do women know that prenatal testing detects fetuses with Down syndrome?
    Jaques AM; Halliday JL; Bell RJ
    J Obstet Gynaecol; 2004 Sep; 24(6):647-51. PubMed ID: 16147604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding pregnant women's decision making concerning prenatal screening.
    van den Berg M; Timmermans DR; Knol DL; van Eijk JT; de Smit DJ; van Vugt JM; van der Wal G
    Health Psychol; 2008 Jul; 27(4):430-7. PubMed ID: 18643000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's attitudes to the successive decisions possibly involved in prenatal screening for Down syndrome: how consistent with their actual decisions?
    Seror V; Ville Y
    Prenat Diagn; 2010 Nov; 30(11):1086-93. PubMed ID: 20872424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting Down syndrome screening results: women's understanding of risk.
    Nagle C; Hodges R; Wolfe R; Wallace EM
    Prenat Diagn; 2009 Mar; 29(3):234-9. PubMed ID: 19177342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result.
    Kobelka C; Mattman A; Langlois S
    Prenat Diagn; 2009 May; 29(5):514-9. PubMed ID: 19242922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amniocentesis decision: ten years of decision analytic experience.
    Pauker SP; Pauker SG
    Birth Defects Orig Artic Ser; 1987; 23(2):151-69. PubMed ID: 3593909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can we improve the content and quality of information delivered prior to amniocentesis?].
    Malkiel A; Granat M; Sagi M; Brezis M
    Harefuah; 2008 Jan; 147(1):16-20, 96, 95. PubMed ID: 18300617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term trends for socio-economic differences in prenatal diagnosis of Down syndrome: diffusion of services or persistence of disparities?
    Khoshnood B; De Vigan C; Blondel B; Vodovar V; Cadio E; Goffinet F
    BJOG; 2008 Aug; 115(9):1087-95. PubMed ID: 18518869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of prenatal diagnosis and termination of pregnancies for the prevention of Down syndrome in Israel.
    Zlotogora J; Haklai Z; Leventhal A
    Isr Med Assoc J; 2007 Aug; 9(8):600-2. PubMed ID: 17877067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.